Investment Rating - The report maintains a positive outlook on the pharmaceutical sector, indicating an "Overweight" rating for the industry, suggesting it will outperform the overall market [1]. Core Insights - The report highlights that the commercialization of innovative drugs, combined with licensing income, is expected to lead to profitability for several companies in 2025, including BeiGene, Innovent Biologics, and others [1][9]. - The Pharma sub-sector is projected to achieve a revenue growth rate of 15-20% in 2025 for companies like Hansoh Pharmaceutical and China Biologic Products, with a significant revenue increase expected for 3SBio due to a major business development deal with Pfizer [2][10]. - The CXO sector is also expected to show strong performance, with companies like WuXi AppTec forecasting a revenue increase of approximately 15.84% and a net profit growth of about 102.65% in 2025 [3][11]. - In the medical services sector, the report notes that valuations are at historical lows, with a projected revenue growth of 13% for GuoShengTang in 2025, emphasizing the importance of overseas business expansion and AI integration in traditional Chinese medicine [4][12]. Summary by Sections Innovative Drugs - The report anticipates that several innovative drug companies will reach profitability in 2025 due to increased commercialization and business development income [9][15]. Pharma - The Pharma sub-sector is expected to see a revenue growth of 15-20% in 2025 for key players, with 3SBio projected to achieve over 100% growth due to a significant partnership with Pfizer [2][10]. CXO - WuXi AppTec is expected to report a revenue of approximately 454.56 billion RMB in 2025, with a net profit growth of around 102.65% [3][11]. Medical Services - GuoShengTang is projected to have a revenue growth of 13% in 2025, with a focus on overseas acquisitions and AI applications in traditional medicine [4][12].

Market Overview - The Hong Kong stock market opened under pressure, with the Hang Seng Index down 1.97%, the National Enterprises Index down 1.88%, and the Hang Seng Tech Index down 2.42% [1][3] - Major stocks such as Baidu Group, Zijin Mining, AIA, and JD Health experienced declines of 4.33%, 4.14%, 4.02%, and 3.96% respectively [1][3] - Only a few blue-chip stocks, including Mengniu Dairy, Midea Group, and New Oriental, recorded slight gains [1][3] Company Specifics - China Overseas Development reported a 20.4% year-on-year increase in contract property sales amounting to approximately RMB 144.78 billion in January, while the sales area decreased by 12.9% to about 516,600 square meters [1][3] - The company anticipates that approximately RMB 111.46 billion in recognized property sales will convert into contract property sales in the coming months [1][3] - Meituan plans to acquire all issued shares of Dingdong, a leading fresh e-commerce company in mainland China, for an initial cost of USD 717 million, which is subject to adjustments [1][3] - NIO reported a positive earnings forecast, expecting adjusted operating profit (non-GAAP) between RMB 700 million (approximately USD 100 million) and RMB 1.2 billion (approximately USD 172 million) for Q4 2025, marking its first quarter of adjusted operating profit [2][4] - In contrast, NIO recorded an adjusted operating loss of RMB 5.5436 billion in Q4 2024 [2][4]

Core Viewpoint - The Nasdaq Golden Dragon China Index saw an initial increase of 1.21%, indicating positive market sentiment towards Chinese stocks listed in the U.S. [1] Company Performance - NIO experienced a significant rise of 7.4% - Miniso increased by 5.4% - Yum China rose by 3.4% - Li Auto gained 2.8% - ZTO Express, Zai Lab, Bilibili, Baidu, and Kingsoft Cloud all saw increases of over 2% - Alibaba had a modest increase of 0.7% - Pony.ai declined by 1.2% - New Oriental fell by 2.8% [1] ETF Performance - KWEB ETF rose by 1.14% - CQQQ ETF increased by 0.7% - ASHR ETF decreased by 0.1% - ASHS ETF fell by 1.3% [1]

来源：中国网 2月3日，2025年"中国大学生自强之星"活动分享会在北京交通大学科学会堂举行。本次活动由共青团中 央基层建设部指导，中国青年报社、中国青少年发展基金会主办，新东方教育科技集团协办，聚焦立德 树人根本任务，深入挖掘在爱国奉献、道德弘扬、科技创新、自主创业、志愿公益、身残志坚、自立自 强等方面事迹突出的新时代大学生先进典型，树立青年榜样。本年度共产生1000名"中国大学生自强之 星"个人及100个"中国大学生自强之星科创团体"。 "中国大学生自强之星"评选活动于2007年启动，新东方先后共出资1亿元，在全国范围内寻访青年榜 样。十八年来，活动共产生1.5万余名"中国大学生自强之星"。值得一提的是，自2024年度首次增设"科 创团体"类别以来，该类别累计获奖团体已达200个。他们与个人获奖者共同构建起更为立体、多元的青 年榜样群像，展现出新时代大学生在科技创新与团队协作中的蓬勃朝气与担当精神。 分享会伊始，北京交通大学党委常委、副校长李国岫在致辞中指出，自强的学子"用很真实的奋斗诠释 着新时代青年的优秀"，他们将自信、自立、自强内化为人生信条，将个人奋斗融入了时代洪流。他强 调，学校通过"将外在的资 ...

Core Viewpoint - New Oriental Education (EDU) has shown strong performance in the Consumer Discretionary sector, outperforming its peers significantly in year-to-date returns [1][4]. Company Performance - New Oriental Education has a Zacks Rank of 1 (Strong Buy), indicating a favorable outlook based on earnings estimate revisions [3]. - The Zacks Consensus Estimate for EDU's full-year earnings has increased by 5.6% in the past quarter, reflecting improved analyst sentiment [4]. - Year-to-date, EDU has returned 15.4%, while the average return for Consumer Discretionary stocks has been a loss of 5.2%, showcasing its superior performance [4]. Industry Context - New Oriental Education is part of the Schools industry, which consists of 17 stocks and currently ranks 84 in the Zacks Industry Rank [6]. - The average return for stocks in the Schools industry has been 5.9% this year, indicating that EDU is performing better than the industry average [6]. - In comparison, another stock in the Consumer Discretionary sector, Sleep Number (SNBR), has a year-to-date return of 39.6% and a Zacks Rank of 2 (Buy) [5].

Group 1 - As of February 4, 100 stocks reached a 52-week high, with METROPOLIS CAP (08621), Asia Backup (08290), and Wenling Tooling (01379) leading the high rate at 74.55%, 63.89%, and 57.48% respectively [1] - METROPOLIS CAP closed at 0.048 with a peak of 0.096, while Asia Backup closed at 0.032 with a peak of 0.059, and Wenling Tooling closed at 3.400 with a peak of 6.000 [1] - Other notable stocks that reached new highs include Asia Internet Technology (00679) at 46.23% and Asia Pacific Financial Investment (08193) at 25.45% [1] Group 2 - The 52-week low rankings show that Gaodi Co. (01676) had the largest decline at -45.71%, followed by Xixiang Group (02473) at -23.42% and Jianfa Xingsheng (00731) at -21.51% [3] - Gaodi Co. closed at 0.243 with a low of 0.171, while Xixiang Group closed at 2.370 with a low of 2.060, and Jianfa Xingsheng closed at 0.137 with a low of 0.135 [3] - Other significant declines include Huaxia SOL-R (83460) at -14.34% and Huaxia SOL-U (09460) at -13.97% [3]

New Oriental Education (EDU) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this educational services provider reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlat ...

Core Viewpoint - The article discusses the momentum investing strategy, highlighting New Oriental Education (EDU) as a promising stock with a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy) [2][3][12]. Company Performance - New Oriental Education's shares have increased by 4.7% over the past week, while the Zacks Schools industry has decreased by 1.41% during the same period [6]. - Over the last quarter, shares of EDU have risen by 12.52%, and over the past year, they have gained 27.06%, compared to the S&P 500's increases of 2.29% and 16.86%, respectively [7]. - The average 20-day trading volume for EDU is 1,075,201 shares, indicating a bullish sign as the stock is rising with above-average volume [8]. Earnings Outlook - In the past two months, four earnings estimates for EDU have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $3.56 to $3.74 [10]. - For the next fiscal year, four estimates have also moved upwards without any downward revisions [10]. Investment Recommendation - Given the positive momentum indicators and earnings outlook, New Oriental Education is recommended as a strong buy for investors looking for short-term opportunities [12].

Core Viewpoint - Investors in the Schools sector should consider New Oriental Education (EDU) and Universal Technical Institute (UTI), with EDU currently presenting a better value opportunity [1] Group 1: Zacks Rank and Earnings Outlook - New Oriental Education has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while Universal Technical Institute has a Zacks Rank of 5 (Strong Sell) [3] - The Zacks Rank system favors stocks with positive revisions to earnings estimates, suggesting that EDU has an improving earnings outlook [3] Group 2: Valuation Metrics - EDU has a forward P/E ratio of 16.61, significantly lower than UTI's forward P/E of 37.77, indicating that EDU may be undervalued [5] - EDU's PEG ratio is 0.89, while UTI's PEG ratio is 2.52, further suggesting that EDU is a more attractive investment based on expected earnings growth [5] - EDU's P/B ratio is 2.33 compared to UTI's P/B of 4.81, reinforcing the notion that EDU is the superior value option [6] Group 3: Value Grades - EDU has a Value grade of A, while UTI has a Value grade of D, highlighting the significant difference in their valuation metrics and earnings outlook [6]

新东方港股今日大涨6.4%，带动新东方(EDU.US)美股盘前涨3%。自公司公布业绩以来股价表现活跃。 消息上，绩后获多家机构唱好。海通国际最新发布研报称，新东方2026财年次季总营收年增15%至 11.91亿美元，超出市场一致预期3%，且突破公司此前9%至12%的指引上限。该行对新东方2026财年 Non-Gaap净利润率仍采用18倍市盈率进行估值。麦格理发表报告指，新东方旗下核心教育业务与东方 甄选业务共同推动2026财年第二季度利润率胜预期。美股目标价由48.3美元上调至50美元。大和发表研 报指，新东方2026财年次季度业绩胜市场预期，主要受惠于其教育业务盈利能力改善及东方甄选的贡 献。该行将新东方2027至2028年每股盈利预测上调0.4%至1.4%，重申港股"买入"评级。 | EDU 新东方 | | | | --- | --- | --- | | 62.080 + +1.700 +2.82% | | 收盘价 02/02 16:00 美东 | | 64.000 ↑ 1.920 +3.09% | | 盘前价 02/03 04:16 美东 | | 三 71 24 华 S 9 日 ♥ 白选 | | ● 快 ...